Nymox Pharmaceutical Corporation (NYMXF)
OTCMKTS · Delayed Price · Currency is USD
0.0659
-0.0057 (-7.96%)
May 6, 2026, 10:11 AM EST
Nymox Pharmaceutical Market Cap
Nymox Pharmaceutical has a market cap or net worth of $7.31 million as of May 6, 2026. Its market cap has decreased by -3.40% in one year.
Market Cap
7.31M
Enterprise Value
10.52M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.07
Market Cap Chart
Since November 26, 1997, Nymox Pharmaceutical's market cap has decreased from 118.04M to 7.31M, a decrease of -93.81%. That is a compound annual growth rate of -9.32%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 4, 2026 | 7.31M | 78.11% |
| Dec 31, 2025 | 4.10M | -56.61% |
| Dec 31, 2024 | 9.45M | -82.82% |
| Dec 29, 2023 | 55.03M | 86.49% |
| Dec 30, 2022 | 29.51M | -73.23% |
| Dec 31, 2021 | 110.23M | -42.54% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Biomind Labs | 9.31M |
| Zenith Capital | 8.79M |
| NKGen Biotech | 7.84M |
| BetterLife Pharma | 7.66M |
| Brainstorm Cell Therapeutics | 7.17M |
| Synlogic | 6.97M |
| Curative Biotechnology | 6.48M |
| TRON Group | 5.98M |